Trials / Conditions / Aicardi-Goutières Syndrome (AGS)
Aicardi-Goutières Syndrome (AGS)
4 registered clinical trials studyying Aicardi-Goutières Syndrome (AGS).
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Evaluate the Efficacy of Anti-Jak1 Inhibitors as Treatment for Patients With Aicardi-Goutières Syndrome NCT06898372 | IRCCS Fondazione Stella Maris | — |
| Terminated | TPN-101 in Aicardi-Goutières Syndrome (AGS) NCT05613868 | Transposon Therapeutics, Inc. | Phase 2 |
| Completed | Reverse Transcriptase Inhibitors in AGS NCT02363452 | Assistance Publique - Hôpitaux de Paris | Phase 2 |
| Approved For Marketing | Compassionate Use Protocol for the Treatment of Autoinflammatory Syndromes NCT01724580 | Eli Lilly and Company | — |